Tuesday, September 1, 2026
8:00 - 9:00 AM ET
Location: Webinar Registration required
Jill A Fisher, Ph.D.
To register: https://forms.gle/5HCh53h3mYcXeWay6
Agenda
Introduction (VOLRETHICS Board)
Presentation: Women in Phase I trials, by Jill A Fisher, Ph.D., based on several publications:
- Waltz, M., A. D. Lyerly, and J. A. Fisher, “Exclusion of Women from Phase I Trials: Perspectives from Investigators and Research Oversight Officials,” Ethics & Human Research 45, no. 6 (2023): 19-30. Doi: 10.1002/eahr.500170
- Cottingham M.D., Fisher, JA, Gendered Logics of Biomedical Research Women in U.S. Phase I Clinical Trials, Social Problems, 2022, 69, 492–509 Doi: 10.1093/socpro/spaa035.
- Jain N, Cottingham M.D., Fisher, JA, Disadvantaged, outnumbered, and discouraged: women’s experiences as healthy volunteers in U.S. Phase I trials, CRITICAL PUBLIC HEALTH, 2020, VOL. 30, NO. 2, 141–152, Doi: 10.1080/09581596.2018.1529861.
Discussant: Beyond Phase I trials: inclusion of women in clinical trials, by Craig Tipple, MD (Drugs for Neglected Diseases initiative, Geneva, Switzerland).
Open Discussion
Conclusion (VOLRETHICS)